Drug Patent Watch

DECEMBER 17, 2024

Flexibility has become more than just a buzzword it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. But what exactly makes flexibility so important for CDMOs, and how can they cultivate this essential trait? Let’s dive into the world of pharmaceutical outsourcing and explore why adaptability is the key to success.

Manufacturing 74

Manufacturing Production Development Big Data 74

Imperical Blog

DECEMBER 18, 2024

Our blog team reviewed our 2024 clinical study blogs, and we selected these six worth re-reading. Check them out! 1. Sustainability in Business: Transparency and Keeping Score ESG: Environmental, social, and governance are factors that influence commercial success. Discover how Imperial achieved a sustainability rating… The post 6 Clinical Study Blogs Not to Miss appeared first on Imperial Clinical Research Services Blog.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Drug Patent Watch

DECEMBER 16, 2024

When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various tools to find relevant information. Google Patents, with its user-friendly interface and vast database, might seem like an ideal resource. However, there are several reasons why relying solely on Google Patents can be risky, especially in the context of pharmaceutical patents.

Drugs 52

Drugs Marketing Research Manufacturing 52

Fierce Pharma

DECEMBER 17, 2024

Its not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisks diabetes superstar Ozempic and blindness? | After the recent release of two independent studies from the University of Southern Denmark suggested the use of Ozempic increases patients' chances of developing a rare eye disorder, the Danish Medicines Agency has asked European officials to investigate.

Medicine 109

Medicine Development 109

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.

Compliance

Advarra

DECEMBER 17, 2024

2024 has been a year of growth and evolution in clinical research. The coming year is expected to be no different. As we look to 2025, Advarra thought leaders have compiled predictions and perspectives on key topics shaping the industry. These topics include perspectives on how artificial intelligence (AI) will be leveraged in clinical research, key regulatory trends shaping the industry, the movements of site consolidation, the continued challenges (and potential solutions) of study startup, an

Clinical Research 98

Clinical Research Research Trials Clinical Trials 98

Worldwide Clinical Trials

DECEMBER 19, 2024

At the recent World Orphan Drug Congresses (WODC) in Europe and the United States, Worldwide Clinical Trials Derek Ansel , Vice President, Therapeutic Strategy Lead, Rare Disease, facilitated roundtable discussions to explore the operational challenges and ethical barriers surrounding genetic testing. While the agenda remained the same across both events, the conversations revealed key regional distinctions and global perspectives on how genetic testing, ethics, and operational challenges are ad

Genetics 130

Genetics In-Vitro Drugs Clinical Trials 130

Rethinking Clinical Trials

DECEMBER 18, 2024

Speaker Gbenga Ogedegbe, MD, MPH, FACP Dr. Adolph & Margaret Berger Professor of Population Health NYU Grossman School of Medicine Director, Institute for Excellence in Health Equity (IEHE) NYU Langone Health Slides Keywords Hypertension; Racial Disparities; Case Management; Telemonitoring Key Points There are significant racial disparities when it comes to stroke outcomes in the U.S., with Black and Hispanic populations experiencing poorer outcomes than Caucasian

Nurses 100

Nurses Clinical Trials Clinical Trials Trials 100

XTalks

DECEMBER 18, 2024

Neurocrine Biosciences Crenessity (crinecerfont) has been given the green light by the US Food and Drug Administration (FDA) as a new treatment for congenital adrenal hyperplasia (CAH). The approval marks a significant step in addressing a condition that has historically relied on decades-old therapies. The therapy is approved to be used in combination with glucocorticoid replacement therapies (steroids) to control androgen levels in adults and pediatric patients four years of age and older with

Genetics 116

Genetics Hormones Trials Drugs 116

Pharmaceutical Technology

DECEMBER 19, 2024

MSD has entered an exclusive global licence agreement with Hansoh Pharma for a preclinical oral small molecule GLP-1RA.

264

264

Bio Pharma Dive

DECEMBER 19, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Pharmacy 284

Pharmacy Marketing 284

Advertisement

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

Trials

Rethinking Clinical Trials

DECEMBER 17, 2024

December 8, 2024 : The NIH Pragmatic Trials Collaboratory hosted a workshop at AcademyHealth's 17th Annual Conference on the Science of Dissemination and Implementation in Health. The workshop introduced concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a focus on methods relevant to health services researchers.

Trials 130

Trials Research Clinical Trials Clinical Trials 130

XTalks

DECEMBER 19, 2024

Mental health problems represent a critical area of unmet need worldwide, affecting an estimated one in eight people globally, according to the World Health Organization (WHO). These issues carry substantial personal and societal costs, impacting daily life and productivity. In fact, mental health conditions are associated with a 10- to 25-year reduction in life expectancy , emphasizing the need for effective and accessible treatments.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Research 97

Pharmaceutical Technology

DECEMBER 18, 2024

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

Insulin 264

Insulin Drugs 264

Bio Pharma Dive

DECEMBER 16, 2024

The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 testing.

Drugs 284

Drugs 284

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Rethinking Clinical Trials

DECEMBER 16, 2024

A new study snapshot and updated ethics and regulatory documentation are now available for the I CAN DO Surgical ACP trial. As part of the study’s transition from the planning phase to the implementation phase this fall, the investigators reviewed and updated the minutes of their initial consultation with the Ethics and Regulatory Core. Read the updated ethics and regulatory documentation See the study snapshot I CAN DO Surgical ACP, an NIH Collaboratory Trial, is testing a system-based ap

Clinical Trials 130

Clinical Trials Clinical Trials Trials 130

XTalks

DECEMBER 16, 2024

Imagine having a heart monitoring device small enough to fit in a purse or a wallet, ready to record critical heart data whenever symptoms arise. This device by HeartBeam, Inc. is a breakthrough in at-home cardiac care, allowing patients to capture high-quality electrocardiograms (ECGs) wherever they are. When symptoms occur, patients simply place the device on their chest and follow prompts from a companion app.

Production 92

Production Drugs Research Cardiology 92

Pharmaceutical Technology

DECEMBER 18, 2024

Abera and Orexo have entered a partnership to develop and test the powder formulations of the formers vaccine candidates.

Vaccine 264

Vaccine Vaccination Development 264

Bio Pharma Dive

DECEMBER 17, 2024

Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and Roche, each of which were acquired in multibillion-dollar deals.

Medicine 274

Medicine Drugs 274

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 16, 2024

Children with attention deficit hyperactivity disorder ( ADHD) do not have a behavioural disorder, nor are they lazy, or lacking in manners and boundaries. Their brains mature in a different way, with different patterns of neurological activity and a number of neurochemical differences. For this reason, ADHD is considered to be a neurodevelopmental disorder.

Clinical Trials 245

Clinical Trials Clinical Trials Trials 245

Pharma Times

DECEMBER 17, 2024

First patient dosed in landmark trial for GAD treatment

Trials 139

Trials 139

Pharmaceutical Technology

DECEMBER 17, 2024

Construction has already begun on the Ozempic-producers new Denmark production facility and 40,000m2 warehouse.

Production 263

Production 263

Bio Pharma Dive

DECEMBER 19, 2024

Even with another mid-stage setback, Roche believes there were enough positive signs to “merit further exploration” of the drug, which it’s been developing with Prothena for more than a decade.

Drugs 261

Drugs Development 261

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

Compliance

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 18, 2024

People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.

Clinical Trials 243

Clinical Trials Clinical Trials Drugs Trials 243

XTalks

DECEMBER 16, 2024

Maria Hopfgarten Head of Global Medical Writing PPD Clinical Research Business of Thermo Fisher Scientific Artificial intelligence (AI) is revolutionizing industries worldwide, and medical writing is no exception. With the integration of human intelligence (HI) with AI, the field is discovering new efficiencies and maintaining, or even improving, the rigor required for quality and compliance.

Compliance 52

Compliance Clinical Research Clinical Trials Clinical Trials 52

Pharmaceutical Technology

DECEMBER 16, 2024

Discover the latest advancements in small cell lung cancer through Novotech CROs in-depth disease analysis.

Clinical Trials 246

Clinical Trials Clinical Trials Trials 246

Bio Pharma Dive

DECEMBER 18, 2024

“Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The company plans to use its new funds to get to “proof of concept” for its medicines.

Development 261

Development Medicine Drugs 261

Advertisement

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

Life Science

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 15, 2024

The human body can survive without food for some time before starvation risks causing significant harm to the body.

Research 241

Research Clinical Trials Clinical Trials Trials 241

Pharma Times

DECEMBER 17, 2024

New CT-guided radiotherapy system offers personalised cancer treatment

137

137

Pharmaceutical Technology

DECEMBER 20, 2024

Novo Nordisk has announced positive results from its Phase III trial of CagriSema but fell short of a previously promised 25% weight loss.

Trials 162

Trials 162

Bio Pharma Dive

DECEMBER 17, 2024

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.

FDA Approval 237

FDA Approval Antibody Drugs 237

Advertisement

Clinical Supply